Stericycle (SRCL) Stock Price, News & Analysis

Company Overview

Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions. It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

Key Stats

• Today's Range: $61.69 to $61.73
• 50-Day Range: $58.09 to $61.71
• 52-Week Range: $37.78 to $61.77
• Volume: 421,196 shs
• Average Volume: 1.10 million shs
• Market Capitalization: $5.73 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $74.00
• Consensus Rating: Hold

Stericycle Stock Analysis - MarketRank™

Stericycle scored higher than 80% of companies evaluated by MarketBeat, and ranked 74th out of 344 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Stericycle has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 2 buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Stericycle has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 19.21%

Earnings Growth

Earnings for Stericycle are expected to grow by 19.21% in the coming year, from $2.29 to $2.73 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stericycle is -280.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stericycle is -280.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Stericycle has a PEG Ratio of 3.37. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stericycle has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.56% of the outstanding shares of Stericycle have been sold short.

Short Interest Ratio / Days to Cover

Stericycle has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stericycle has recently increased by 2.92%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Stericycle does not currently pay a dividend.

Dividend Growth

Stericycle does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.10

Percentage of Shares Shorted

4.56% of the outstanding shares of Stericycle have been sold short.

Short Interest Ratio / Days to Cover

Stericycle has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stericycle has recently increased by 2.92%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.07

News Sentiment

Stericycle has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Stericycle this week, compared to 4 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Stericycle insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.93% of the stock of Stericycle is held by insiders.

Percentage Held by Institutions

98.82% of the stock of Stericycle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SRCL Stock Analysis - Frequently Asked Questions

How have SRCL shares performed this year?

Stericycle's stock was trading at $49.56 at the start of the year. Since then, SRCL stock has increased by 24.5% and is now trading at $61.70.
View the best growth stocks for 2024 here.

How were Stericycle's earnings last quarter?

Stericycle, Inc. (NASDAQ:SRCL) issued its quarterly earnings data on Thursday, July, 25th. The business services provider reported $0.61 EPS for the quarter, topping the consensus estimate of $0.57 by $0.04. The business services provider had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a trailing twelve-month return on equity of 7.94%.

Does Stericycle have any subsidiaries?

Stericycle subsidiaries include these companies: LiveAnswer, InQuicker, Shred-it, PSC Environmental Service, Healthcare Waste Solutions, MedServe, Ambimed - Gestao Ambiental Lda., and more.

Who are Stericycle's major shareholders?

Top institutional investors of Stericycle include Black Creek Investment Management Inc. (4.00%), Impax Asset Management Group plc (3.15%), Dimensional Fund Advisors LP (2.34%) and Ariel Investments LLC (1.64%).
View institutional ownership trends.

How do I buy shares of Stericycle?

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Stericycle own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM) and Johnson & Johnson (JNJ).

Company Calendar

• Last Earnings: 7/25/2024
• Today: 9/19/2024
• Next Earnings (Estimated): 11/07/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Sanitary services
• Sub-Industry: Environmental & Facilities Services
• Current Symbol: NASDAQ:SRCL
• CUSIP: 85891210
• CIK: 861878
• Web: www.stericycle.com
• Phone: (847) 367-5910
• Fax: 847-367-9493
• Employees: 13,500
• Year Founded: 1989

Price Target and Rating

• Average Stock Price Target: $74.00
• High Stock Price Target: $142.00
• Low Stock Price Target: $48.00
• Potential Upside/Downside: +19.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.17
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 26.95
• P/E Growth: 3.37
• Net Income: $-21,400,000.00
• Net Margins: 1.37%
• Pretax Margin: 2.19%
• Return on Equity: 7.94%
• Return on Assets: 3.71%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 1.13
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $2.66 billion
• Price / Sales: 2.15
• Cash Flow: $4.24 per share
• Price / Cash Flow: 14.57
• Book Value: $27.27 per share
• Price / Book: 2.26

Miscellaneous

• Outstanding Shares: 92,840,000
• Free Float: 91,973,000
• Market Cap: $5.73 billion
• Optionable: Optionable
• Beta: 1.11